These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34422997)

  • 1. Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway.
    Sun Y; Chen K; Lin G; Wan F; Chen L; Zhu X
    Ann Transl Med; 2021 Jul; 9(13):1085. PubMed ID: 34422997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma.
    Chen Q; Zheng W; Zhu L; Yao D; Wang C; Song Y; Hu S; Liu H; Bai Y; Pan Y; Zhang J; Guan J; Shao C
    Front Cell Dev Biol; 2020; 8():232. PubMed ID: 32373608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
    Zhang W; Zhang Y; Xi S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
    Jiang J; Tang Q; Gong J; Jiang W; Chen Y; Zhou Q; Aldeen A; Wang S; Li C; Lv W; Du T; Wang X; Long X; Feng X
    Int J Biol Sci; 2022; 18(5):1878-1895. PubMed ID: 35342334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis.
    Zhong Q; Chen Y; Chen Z
    Cell Cycle; 2020 Jan; 19(1):53-66. PubMed ID: 31760895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway.
    Ma R; Zhao LN; Yang H; Wang YF; Hu J; Zang J; Mao JG; Xiao JJ; Shi M
    Am J Transl Res; 2018; 10(12):4130-4140. PubMed ID: 30662656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.
    Chen L; Lin G; Chen K; Wan F; Liang R; Sun Y; Chen X; Zhu X
    Sci Rep; 2020 Oct; 10(1):16328. PubMed ID: 33004943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy.
    Chu C; Niu X; Ou X; Hu C
    Onco Targets Ther; 2019; 12():5661-5677. PubMed ID: 31410015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway.
    Feng G; Arima Y; Midorikawa K; Kobayashi H; Oikawa S; Zhao W; Zhang Z; Takeuchi K; Murata M
    Cancer Cell Int; 2023 Aug; 23(1):185. PubMed ID: 37644594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.
    Yu X; Zhen Y; Yang H; Wang H; Zhou Y; Wang E; Marincola FM; Mai C; Chen Y; Wei H; Song Y; Lyu X; Ye Y; Cai L; Wu Q; Zhao M; Hua S; Fu Q; Zhang Y; Yao K; Liu Z; Li X; Fang W
    Cell Death Dis; 2013 May; 4(5):e634. PubMed ID: 23681229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
    Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W
    Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
    Han YY; Liu K; Xie J; Li F; Wang Y; Yan B
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.